Document Detail


Assessment of differentiation in adenocarcinoma cells from pleural effusion by peripheral airway cell markers and their diagnostic values.
MedLine Citation:
PMID:  12445749     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ultrastructural studies have shown that Clara cell-type is a more common type of adenocarcinoma than alveolar type II cell-type, and that both types may provide better prognosis than other types, indicating an importance of differentiation toward peripheral airway cells. Pulmonary surfactant protein (SP)-A is a specific marker for both alveolar type II cells and Clara cells in peripheral lung tissues, while SP-C and Clara cell 10 kD protein (CC10) may be particularly and highly specific to alveolar type II cells and Clara cells, respectively. The aims of this study were to assess the differentiation of adenocarcinoma cells in pleural effusions by evaluating the expression of these cell markers and to evaluate their values as diagnostic tools for judging the cause of pleural effusion. We examined pleural effusions from 52 patients; 20 with primary lung adenocarcinomas, 6 with small cell lung carcinomas, 11 with metastatic malignant tumors and 15 with non-neoplastic diseases. The cell pellets from effusions were subjected to immunocytochemical staining for SP-A, proSP-C, a precursor of SP-C, and CC10. By this immunocytochemical study for SP-A and proSP-C, 10 (50%) and 6 (30%) of 20 adenocarcinomas, respectively, showed a positive immunoreactivity in their effusion cells, while none of them expressed CC10. Alveolar type II cells therefore may be the main progenitor cells of some adenocarcinomas. In pleural effusions from patients with primary lung adenocarcinomas, reverse transcriptase-polymerase chain reaction (RT-PCR) for SP-A mRNA showed a sensitivity of 83%, while, in all remaining patients, these assays were negative. In conclusion, we demonstrated that lung adenocarcinomas, which are partially differentiated toward alveolar type II cells, are not as rare as previously thought, and that both the RT-PCR and immunocytochemical analyses for SP-A and pro-SP-C could be worthy indicators of differential diagnosis.
Authors:
Chikako Takezawa; Hiroki Takahashi; Takuya Fujishima; Masanori Shiratori; Yuji Morita; Hitomi Sano; Yoshio Kuroki; Shosaku Abe
Related Documents :
22581829 - Microrna-93 inhibits tumor growth and early relapse of human colorectal cancer by affec...
11369539 - Surfactant proteins and cell markers in the respiratory epithelium of the amphibian, am...
17108109 - Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase l1 gene in hum...
11369549 - Stretch stimulation: its effects on alveolar type ii cell function in the lung.
8368329 - Pulmonary surfactant protein a-mediated uptake of phosphatidylcholine by alveolar type ...
6093659 - Lung damage induced by butylated hydroxytoluene in mice. biochemical, cellular, and mor...
21249379 - Short- and long-term effects of small bowel resection: a unique histological study in a...
15812239 - Spatial and temporal changes in the subcellular localization of the nuclear protein-tyr...
19584809 - Generation of single-cell suspensions from mouse neural tissue.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Lung cancer (Amsterdam, Netherlands)     Volume:  38     ISSN:  0169-5002     ISO Abbreviation:  Lung Cancer     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-11-26     Completed Date:  2003-06-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8800805     Medline TA:  Lung Cancer     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  273-81     Citation Subset:  IM    
Affiliation:
Third Department of Internal Medicine, Sapporo Medical University School of Medicine, South-1, West-16, Chuo-ku, Sapporo 060-8543, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / diagnosis,  metabolism*
Diagnosis, Differential
Enzyme-Linked Immunosorbent Assay
Humans
Immunoenzyme Techniques
Lung Neoplasms / diagnosis,  metabolism*
Pleural Effusion, Malignant / metabolism*
Pulmonary Surfactant-Associated Proteins / analysis
RNA, Neoplasm / analysis
Reverse Transcriptase Polymerase Chain Reaction
Statistics, Nonparametric
Chemical
Reg. No./Substance:
0/Pulmonary Surfactant-Associated Proteins; 0/RNA, Neoplasm

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The characteristics of early bronchogenic carcinoma evaluated by cytomorphological features.
Next Document:  Primary sarcomas of the lung: a clinicopathologic study of 12 cases.